Danielle D. Mendonca

Danielle D. Mendonca

Auto-generated profile, based on publicly available information

Danielle D. Mendonca

Baylor College of Medicine 2 Department of Pediatrics, Section of Immunology, Allergy and Retrovirology Houston, TX

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2023 in Stem Cell Research
Verified
Journal Article
Open access
DMDanielle Mendonca
Danielle Mendonca
GCGerarda Cappuccio
Gerarda Cappuccio
JSJennifer Sheppard
Jennifer Sheppard
MDMagdalena Delacruz
Magdalena Delacruz
JBJesse Bengtsson
Jesse Bengtsson
MMMirjana Maletic-Savatic
Mirjana Maletic-Savatic
MECP2 Duplication Syndrome (MDS) is a rare, severe neurodevelopmental disorder arising from duplications in the Xq28 region containing the MECP2 gene that predominantly affects males. We generated five human induced pluripotent stem cell (iPSC) lines from the fibroblasts of individuals carrying between 0.355 and 11.2 Mb size duplications in the chromosomal locus containing MECP2. All lines underwent extensive testing to confirm MECP2 duplication and iPSC-related features such as morphology, pluripotency markers, and trilineage differentiation potential. These lines are a valuable resource for molecular and functional studies of MDS as well as screening for a variety of therapeutic approaches.

23 April 2025 in Journal of Human Immunity
Verified
Journal Article
Open access
JHJoud Hajjar
Joud Hajjar
AVAnita Y. Voigt
Anita Y. Voigt
MCMargaret E. Conner
Margaret E. Conner
ASAlton G. Swennes
Alton G. Swennes
SFStephanie Fowler
Stephanie Fowler
JPJoseph F. Petrosino
Joseph F. Petrosino
Patients with common variable immunodeficiency (CVID) who develop noninfectious complications (NIC) have worse clinical outcomes than those with infections only (INF). While gut microbiome aberrations have been linked to NIC, reductionist animal models that accurately recapitulate CVID are lacking. Our aim in this study was to uncover potential microbiome roles in the development of NIC in CVID. We performed whole-genome shotgun sequencing on fecal samples from CVID patients with NIC, INF, and their household controls. We also performed fecal microbiota transplants from CVID patients to germ-free mice. We found potentially pathogenic microbes Streptococcus parasanguinis and Erysipelatoclostridium ramosum were enriched in gut microbiomes of CVID patients with NIC. In contrast, Fusicatenibacter saccharivorans and Anaerostipes hadrus, known to suppress inflammation and promote healthy metabolism, were enriched in gut microbiomes of INF CVID patients. Fecal microbiota transplant from NIC, INF, and their household controls into germ-free mice revealed gut dysbiosis patterns only in recipients from CVID patients with NIC, but not in those from INF CVID or household controls recipients. Our findings provide a proof of concept that fecal microbiota transplant from CVID patients with NIC to germ-free mice recapitulates microbiome alterations observed in the donors.

28 August 2026 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
DMDanielle Mendonca
Danielle Mendonca
MZMatt S. Zinter
Matt S. Zinter
SDSunjay R. Devarajan
Sunjay R. Devarajan
JBJason Boehme
Jason Boehme
BSBernhard Suter
Bernhard Suter
DPDavut Pehlivan
Davut Pehlivan